Literature DB >> 3728799

Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases.

D Raoult, P J Weiller, A Chagnon, H Chaudet, H Gallais, P Casanova.   

Abstract

Most previous studies of Mediterranean spotted fever (MSF) have included cases that either were not laboratory-confirmed or were confirmed by the Weil-Felix test. The authors report the detailed clinical, laboratory and epidemiological features of 199 serologically-confirmed cases of MSF (by microimmunofluorescence). This work demonstrates that the disease is difficult to diagnose, especially at the beginning; that it can be fatal (2.5% of cases); and that a rapid and specific diagnosis is necessary to identify atypical cases. Epidemiological features such as season (summer essentially), presence of a dog, and travel in an endemic area (the Mediterranean Basin) are important in the diagnosis. In such cases fever associated with rash have to be considered and treated as MSF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728799     DOI: 10.4269/ajtmh.1986.35.845

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  43 in total

1.  Clinical and laboratory characteristics of 144 patients with mediterranean spotted fever.

Authors:  E Antón; B Font; T Muñoz; I Sanfeliu; F Segura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

Review 2.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

3.  Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever.

Authors:  F Gudiol; R Pallares; J Carratala; F Bolao; J Ariza; G Rufi; P F Viladrich
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

4.  [Rickettsiosis subsequent to vacation in Swaziland].

Authors:  A S Büchau; J U Würthner; M Bylaite; G Kukova; T Ruzicka; J Reifenberger
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

Review 5.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

6.  Malignant boutonneuse fever and polymyalgia rheumatica: a coincidental association?

Authors:  G Chaumentin; T Zénone; C Bibollet; G A Denoyel; A Boibieux; F Biron; D Peyramond
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

7.  Lack of co-transmission of Rickettsia conorii and Ehrlichia canis in human beings in the south of France.

Authors:  P Brouqui; D Raoult; E Vidor
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

8.  Evidence for a high prevalence of spotted fever group rickettsial infections in diverse ecologic zones of Inner Mongolia.

Authors:  Q H Liu; G Y Chen; Y Jin; M Te; L C Niu; S P Dong; D H Walker
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Ciprofloxacin therapy for Mediterranean spotted fever.

Authors:  D Raoult; H Gallais; P De Micco; P Casanova
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

10.  Human case of Rickettsia felis infection, Taiwan.

Authors:  Kun-Hsien Tsai; Hsiu-Ying Lu; Jih-Jin Tsai; Sheng-Kai Yu; Jyh-Hsiung Huang; Pei-Yun Shu
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.